Synta rallies as drug stocks slip
February 09, 2011 at 10:28 AM EST
Shares of Synta jump a day after the company announced the beginning of Phase I testing for its leukemia drug elesclomol.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.